Treatment of pre-extensively drug-resistant tuberculosis in a 4-month-old infant using a regimen of bedaquiline, delamanid, and contezolid
European Journal of Clinical Microbiology & Infectious Diseases · 2025
DOI: 10.1007/s10096-025-05128-2 ↗Kurz gefasst
Fallbericht in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2025. Verfasst von Wenrui Ding und 5 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Infectious Diseases, Kunming Children's Hospital, Kunming, Yunnan, 650000, China. Hauptthemen laut MEDLINE: Antitubercular Agents, Diarylquinolines, Nitroimidazoles, Oxazoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Drug-resistant tuberculosis (TB) is a significant global challenge, especially in children, where diagnosis and treatment are difficult. This report describes a 4-month-old male infant with pre-extensively drug-resistant tuberculosis (pre-XDR-TB) successfully treated with bedaquiline, delamanid, and contezolid. The patient, born prematurely, developed severe pulmonary TB after exposure to drug-resistant TB from the mother. After discontinuing the initial regimen due to adverse effects, the adjusted regimen resulted in negative TB culture conversion, significant pulmonary improvement, and no notable adverse effects. CLINICAL TRIAL NUMBER: Not applicable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Second Department of Infectious Diseases, Kunming Children's Hospital, Kunming, Yunnan, 650000, China.
- Department of Comprehensive Tuberculosis (Tuberculosis Ward III), The Third People's Hospital of Kunming City, Kunming, Yunnan, China.
- Second Department of Infectious Diseases, Kunming Children's Hospital, Kunming, Yunnan, 650000, China. wangyanchun020@163.com.
- Second Department of Infectious Diseases, Kunming Children's Hospital, Kunming, Yunnan, 650000, China. luoyonghan050@163.com.
- Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, Yunnan, China. luoyonghan050@163.com.
Zitieren
APA
Ding, W., Shen, L., Li, R., Yang, X., Wang, Y., & Luo, Y. (2025). Treatment of pre-extensively drug-resistant tuberculosis in a 4-month-old infant using a regimen of bedaquiline, delamanid, and contezolid. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-025-05128-2
Vancouver
Ding W, Shen L, Li R, Yang X, Wang Y, Luo Y. Treatment of pre-extensively drug-resistant tuberculosis in a 4-month-old infant using a regimen of bedaquiline, delamanid, and contezolid. European Journal of Clinical Microbiology & Infectious Diseases. 2025. doi:10.1007/s10096-025-05128-2
BibTeX
@article{Ding2025,
author = {Ding, Wenrui and Shen, Lingyun and Li, Ruonan and Yang, Xiaotao and Wang, Yanchun and Luo, Yonghan},
title = {Treatment of pre-extensively drug-resistant tuberculosis in a 4-month-old infant using a regimen of bedaquiline, delamanid, and contezolid},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2025},
doi = {10.1007/s10096-025-05128-2}
}
EUVIMED